Metoclopramide is indicated in adults for:
Prevention of delayed chemotherapy induced nausea and vomiting (CINV).
Prevention of radiotherapy induced nausea and vomiting (RINV).
Symptomatic treatment of nausea and vomiting, including acute migraine induced nausea and vomiting. Metoclopramide can be used in combination with oral analgesics to improve the absorption of analgesics in acute migraine.
Metoclopramide is indicated in children (aged 1-18 years) for:
Prevention of delayed chemotherapy induced nausea and vomiting (CINV) as a second line option.
Summary of Product Characteristics
Read this summary of product characteristics for further information about Metoclopramide Hydrochloride Oral Solution. Click below to navigate to the EMC.
Patient Information Leaflet
Read this patient information leaflet about Metoclopramide Hydrochloride Oral Solution, what it’s used for and possible side effects. Click below to navigate to the EMC.
Metoclopramide Hydrochloride Oral Solution
|Click here for Audio Version
|Lemon and lime
|Store below 25°C and protect from light.
|Shelf Life (Closed Bottle/Open Bottle)
|24 months / 1 month
For further product information and pricing please use the form below and a member of the team will be in touch
Stay updated via our App
A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.